Abstract
Melanoma is the most lethal type of skin cancer due to its high metastatic capacity and frequent resistance to available treatments. Targeted therapies and immunotherapies, including immune checkpoint inhibitors, although currently considered gold standard treatment options, are associated with response failure or resistance in around half of melanoma patients. Therefore, the search for n…